table_specific

What was the value of The Standardx's SARs as of December 31, 2022?

The_Standardx Franchise · 2025 FDD

Answer from 2025 FDD Document

end yield assumption is based on the expected annualized dividend payment at the date of grant.

During the years ended December 31, 2024, December 31, 2023, and December 31, 2022, th

Source: Item 10 — OTHER ASSETS (FDD pages 132–156)

What This Means (2025 FDD)

According to The Standardx's 2025 Franchise Disclosure Document, the intrinsic value of exercised SARs (Stock Appreciation Rights) during the year ended December 31, 2022, was $21 million. SARs are a form of equity compensation that allows employees to benefit from the appreciation in the company's stock price over a specific period.

For a prospective franchisee, this information provides insight into the company's financial structure and how it compensates its employees. While franchisees themselves may not directly participate in SAR programs, understanding these compensation mechanisms can offer a broader view of The Standardx's financial health and employee incentives.

The FDD also mentions that the weighted-average grant date fair value for awards granted in 2022 was $37.56. This figure represents the estimated value of SARs at the time they were granted, calculated using the Black-Scholes-Merton option-pricing model. This model considers factors such as the stock price, exercise price, expected life, volatility, risk-free interest rate, and dividend yield to determine the fair value.

Additionally, the number of SARs granted in 2022 was 9,800. This data point, along with the intrinsic value and weighted-average grant date fair value, helps to paint a more complete picture of The Standardx's equity compensation practices and their potential impact on the company's financials. A prospective franchisee might consider these figures as part of their overall assessment of the franchise opportunity.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.